Loading stock data...

Lyka Labs Limited

NSE: LYKALABS BSE: LYKALABS

NSE
100.30 -0.13 (-0.13%)

Prev Close

100.43

Open Price

100.43

Volume

18,009

Today Low / High

98.97 / 100.75

52 WK Low / High

96.71 / 176.59

Range

95 - 105

BSE
99.42 -0.67 (-0.67%)

Prev Close

100.09

Open Price

98.5

Volume

2,560,000

Today Low / High

98.5 / 100.32

52 WK Low / High

90.2 / 175.95

Range

94 - 104

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 100.3 (target range: 95 - 105), reflecting a change of -0.13 (-0.12944%). On the BSE, it is listed at 99.42 (target range: 94 - 104), showing a change of -0.67 (-0.6694%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

22 Sep 100.43 -0.14%
19 Sep 99.84 0.59%
18 Sep 99.98 -0.15%
17 Sep 100.80 -0.86%
16 Sep 99.00 -0.02%
15 Sep 100.95 -2.81%
12 Sep 100.43 -1.10%
11 Sep 100.00 -0.08%
10 Sep 99.50 0.26%
09 Sep 99.40 -0.38%
08 Sep 99.00 -0.10%
05 Sep 101.45 -1.98%
04 Sep 101.79 -2.12%
03 Sep 100.97 0.10%
02 Sep 100.40 0.52%
01 Sep 101.40 -1.73%
29 Aug 101.00 -1.50%
28 Aug 98.57 1.69%
26 Aug 100.45 -0.51%
25 Aug 101.89 -1.47%

Lyka Labs Limited Graph

Lyka Labs Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Lyka Labs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 100.30, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 99.42 100.41 90.37 - 110.46
101.41 81.13 - 121.69
102.40 71.68 - 133.12
Bearish Scenario 99.42 98.43 88.58 - 108.27
97.43 77.95 - 116.92
96.44 67.51 - 125.37

Overview of Lyka Labs Limited

ISIN

INE933A01014

Industry

Biotechnology

Vol.Avg

40,570

Market Cap

3,579,350,100

Last Dividend

0

Official Website

Visit Website

IPO Date

1996-01-01

DCF Diff

-52.47

DCF

152

Financial Ratios Every Investor Needs

Stock Dividend of LYKALABS

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
1996-08-12 August 12, 96 2.5 2.5 1996-09-10 1996-10-01 1996-08-12
1995-09-11 September 11, 95 2.5 2.5 1995-09-11 1995-10-01 1995-08-22

Stock Rating Details for LYKALABS

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 140.73 Cr 55.59 Cr 85.14 Cr 0.6050 0.00 Cr 3.04 Cr 50.50 Cr 8.01 Cr 2.25 20.17 Cr 0.0569
2024-03-31 106.18 Cr 45.19 Cr 60.99 Cr 0.5744 0.00 Cr 2.58 Cr 2.55 Cr -2.49 Cr -0.75 16.76 Cr -0.0234
2023-03-31 88.34 Cr 37.55 Cr 50.78 Cr 0.5749 0.00 Cr 2.88 Cr 2.44 Cr -13.21 Cr -4.57 12.85 Cr -0.1496
2022-03-31 183.59 Cr 53.30 Cr 130.28 Cr 0.7097 0.00 Cr 3.20 Cr 83.09 Cr 39.00 Cr 13.59 101.18 Cr 0.2124
2021-03-31 67.11 Cr 38.18 Cr 28.92 Cr 0.4310 0.00 Cr 2.25 Cr 11.36 Cr -11.55 Cr -4.07 20.12 Cr -0.1722

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 1.34 Cr 176.21 Cr 72.62 Cr 103.5502 Cr 39.18 Cr 37.84 Cr 12.47 Cr 77.10 Cr 0.00 Cr 0.00 Cr 0.02 Cr 46.6313 Cr
2024-03-31 5.95 Cr 156.72 Cr 88.46 Cr 68.1543 Cr 58.65 Cr 52.70 Cr 9.57 Cr 71.12 Cr 0.56 Cr 0.00 Cr 0.07 Cr 37.6402 Cr
2023-03-31 11.71 Cr 151.52 Cr 105.85 Cr 45.4406 Cr 74.63 Cr 62.92 Cr 6.95 Cr 63.76 Cr 0.00 Cr 0.00 Cr 0.04 Cr 32.5980 Cr
2022-03-31 1.35 Cr 185.61 Cr 172.12 Cr 13.3384 Cr 129.66 Cr 128.31 Cr 8.20 Cr 85.97 Cr 0.00 Cr 0.00 Cr 0.01 Cr 99.3527 Cr
2021-03-31 0.24 Cr 190.01 Cr 215.10 Cr -25.7967 Cr 162.63 Cr 162.40 Cr 4.31 Cr 84.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 49.8809 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 1.8994 Cr -11.7960 Cr 5.2920 Cr -13.7554 Cr -4.6047 Cr 1.3441 Cr -15.6548 Cr 8.0120 Cr -19.4695 Cr 0.0000 Cr -2.8937 Cr
2024-03-31 1.7733 Cr -9.4881 Cr 1.9528 Cr -7.4581 Cr -5.7620 Cr 5.9488 Cr -9.2314 Cr -2.4894 Cr -15.9830 Cr 0.0000 Cr -2.6175 Cr
2023-03-31 8.9526 Cr 7.3504 Cr -21.6427 Cr 0.7672 Cr -5.3397 Cr 11.7108 Cr -8.1854 Cr -13.1711 Cr -56.7815 Cr 0.0000 Cr 1.2439 Cr
2022-03-31 79.2461 Cr -6.1720 Cr -63.1773 Cr 71.7333 Cr 9.8969 Cr 17.0505 Cr -7.5129 Cr 59.2470 Cr -40.1915 Cr 0.0000 Cr -3.8919 Cr
2021-03-31 8.8115 Cr -0.1613 Cr -11.7982 Cr 7.5438 Cr -3.1480 Cr 7.1536 Cr -1.2678 Cr -14.1441 Cr -4.9130 Cr 0.0000 Cr 2.4266 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 33.03 Cr 12.74 Cr 20.29 Cr 0.6143 1.57 Cr 0.93 Cr 0.25 4.32 Cr 0.0282
2025-03-31 34.25 Cr 13.08 Cr 21.16 Cr 0.6180 11.55 Cr 1.77 Cr 0.49 5.18 Cr 0.0517
2024-12-31 33.80 Cr 13.06 Cr 20.74 Cr 0.6136 3.36 Cr 2.71 Cr 0.75 6.02 Cr 0.0801
2024-09-30 41.16 Cr 17.95 Cr 23.21 Cr 0.5640 3.19 Cr 2.10 Cr 0.58 4.98 Cr 0.0509
2024-06-30 30.11 Cr 21.45 Cr 8.67 Cr 0.2878 1.95 Cr 1.44 Cr 0.40 4.27 Cr 0.0478

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 1.34 Cr 0.02 Cr 1.36 Cr 43.13 Cr 12.47 Cr 67.43 Cr 77.10 Cr 176.21 Cr 72.62 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.13 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -98.69 Cr
2024-09-30 1.11 Cr 0.02 Cr 6.64 Cr 37.84 Cr 9.69 Cr 58.65 Cr 74.81 Cr 168.25 Cr 69.56 Cr
2024-06-30 0.00 Cr 0.00 Cr 6.29 Cr 0.00 Cr 0.00 Cr 6.29 Cr 0.00 Cr 0.00 Cr -68.27 Cr
2024-03-31 5.95 Cr 0.02 Cr 5.97 Cr 27.05 Cr 9.57 Cr 50.65 Cr 71.12 Cr 156.72 Cr 88.46 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 1.77 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 2.71 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 2.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.44 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 -1.94 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹362.15 ₹483,312,838,605.00 ₹1,278,604.00
Piramal Pharma Limited PPLPHARMA ₹204.57 ₹270,881,178,728.00 ₹1,954,475.00
Syngene International Limited SYNGENE ₹658.60 ₹264,351,754,644.00 ₹320,093.00
Concord Biotech Limited CONCORDBIO ₹1,619.70 ₹169,446,865,619.00 ₹65,728.00
Blue Jet Healthcare Limited BLUEJET ₹678.50 ₹117,696,290,863.00 ₹268,346.00
Jubilant Ingrevia Limited JUBLINGREA ₹690.80 ₹109,240,536,698.00 ₹199,511.00
Supriya Lifescience Limited SUPRIYA ₹740.55 ₹59,601,537,540.00 ₹280,205.00
Dishman Carbogen Amcis Limited DCAL ₹314.10 ₹49,245,567,627.00 ₹1,335,176.00
Zota Health Care Limited ZOTA ₹1,453.40 ₹44,085,480,777.00 ₹20,153.00

Key Executives

Company Secretary & Compliance Officer
Mr. Shekhar R. Singh

Gender: male

Year Born:

MD, Chief Executive Officer & Director
Mr. Kunal Narendra Gandhi

Gender: male

Year Born: 1987

Chief Financial Officer & Executive Director
Mr. Yogesh Babulal Shah

Gender: male

Year Born: 1960

FAQs about Lyka Labs Limited

Who is the CEO of the company?

The CEO is Kunal Narendra Gandhi.

What is the current market price of the stock?

The current price is ₹100.29.

What is the 52-week price range?

The range is ₹96.71-176.59.

What is the market capitalization of the company?

The market capitalization is ₹357.94 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 49.82.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Lyka Labs Limited (ISIN: INE933A01014) is a leading Biotechnology in India. With a market capitalization of ₹357.94 crores and an average daily volume of 40,570 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.